|
US5696109A
(en)
*
|
1992-12-07 |
1997-12-09 |
Eukarion, Inc. |
Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
|
|
US7582786B2
(en)
*
|
1992-12-07 |
2009-09-01 |
Eukarion Inc. |
Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
|
|
US5747026A
(en)
*
|
1993-10-15 |
1998-05-05 |
University Of Alabama At Birmingham Research Foundation |
Antioxidants
|
|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
|
US6440980B1
(en)
*
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
|
US6369106B1
(en)
*
|
1996-12-26 |
2002-04-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
|
|
US6013623A
(en)
*
|
1997-02-27 |
2000-01-11 |
The Trustees Of Columbia University In The City Of New York |
Use of heme-peptides to prevent or retard disease associated with oxidative stress
|
|
US6214817B1
(en)
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
CA2309154C
(en)
|
1997-11-03 |
2010-02-16 |
Duke University |
Substituted porphyrins
|
|
US5922346A
(en)
*
|
1997-12-01 |
1999-07-13 |
Thione International, Inc. |
Antioxidant preparation
|
|
TW408203B
(en)
|
1998-04-06 |
2000-10-11 |
Ciba Sc Holding Ag |
Process for treating textile materials and the relevant compounds
|
|
EP1071419B1
(en)
|
1998-04-21 |
2007-07-25 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Cannabinoids as antioxidants and neuroprotectants
|
|
AU771259B2
(en)
|
1998-04-24 |
2004-03-18 |
Aeolus Sciences, Inc. |
Substituted porphyrins
|
|
WO1999055326A1
(en)
|
1998-04-30 |
1999-11-04 |
Vit-Immune, L.C. |
Method of treatment of glutathione deficient mammals
|
|
GB9817845D0
(en)
|
1998-08-17 |
1998-10-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
ATE552260T1
(de)
*
|
1999-01-25 |
2012-04-15 |
Nat Jewish Health |
Substituierte porphyrine und deren therapeutische verwendung
|
|
US6689733B1
(en)
|
1999-03-08 |
2004-02-10 |
Ciba Specialty Chemicals Corporation |
Manganese complexes of salen ligands and the use thereof
|
|
US20040110722A1
(en)
*
|
1999-05-27 |
2004-06-10 |
Ornberg Richard L. |
Modified hyaluronic acid polymers
|
|
AU5048400A
(en)
*
|
1999-05-27 |
2000-12-18 |
Monsanto Company |
Biomaterials modified with superoxide dismutase mimics
|
|
AUPQ180499A0
(en)
|
1999-07-23 |
1999-08-19 |
Biomolecular Research Institute Limited |
Beta-amyloid peptide inhibitors
|
|
US6179804B1
(en)
*
|
1999-08-18 |
2001-01-30 |
Oxypatch, Llc |
Treatment apparatus for wounds
|
|
AU2001278864A1
(en)
*
|
2000-06-30 |
2002-01-30 |
University Of Cincinnati |
Peptides with antioxidant and antimicrobial properties
|
|
KR100386552B1
(ko)
*
|
2000-08-03 |
2003-06-02 |
한국화인케미칼주식회사 |
올레핀의 비대칭 에폭시화 반응에 유용한 고분자 키랄살렌 유도체
|
|
US6589948B1
(en)
*
|
2000-11-28 |
2003-07-08 |
Eukarion, Inc. |
Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
|
|
US20020072512A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Metaphore Pharmaceuticals, Inc |
Method of preventing and treating HIV-mediated central nervous system damage
|
|
US20050175580A1
(en)
*
|
2001-01-05 |
2005-08-11 |
Daniela Salvemini |
Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
|
|
ATE439134T1
(de)
*
|
2001-01-19 |
2009-08-15 |
Nat Jewish Med & Res Center |
Medikament zum schutz in der radiotherapie
|
|
WO2002058686A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Metaphore Pharmaceuticals, Inc. |
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
|
US20020150582A1
(en)
*
|
2001-02-08 |
2002-10-17 |
Friedrichs Gregory S. |
Method of treating or inhibiting cellular injury or cell death
|
|
AU2002312194B8
(en)
*
|
2001-06-01 |
2008-05-15 |
Aeolus Sciences, Inc. |
Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
|
|
AU2002315001A1
(en)
*
|
2001-06-08 |
2002-12-23 |
Metaphore Pharmaceuticals, Inc. |
Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
|
|
AU784852B2
(en)
*
|
2001-08-10 |
2006-07-06 |
Mars, Incorporated |
Canine support diet
|
|
US20040132706A1
(en)
*
|
2001-10-05 |
2004-07-08 |
Daniela Salvemini |
Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
|
|
JP2005526778A
(ja)
*
|
2002-03-15 |
2005-09-08 |
アストラル，インコーポレイテッド |
免疫調節性非コードｒｎａモチーフを用いて抗体及び主要組織適合性クラスｉ拘束性又はクラスｉｉ拘束性ｔ細胞の応答を開始或いは増強させるための組成物及び方法
|
|
US20070037769A1
(en)
*
|
2003-03-14 |
2007-02-15 |
Multicell Immunotherapeutics, Inc. |
Compositions and methods to treat and control tumors by loading antigen presenting cells
|
|
EP2258712A3
(en)
*
|
2002-03-15 |
2011-05-04 |
Multicell Immunotherapeutics, Inc. |
Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
|
|
EP1513537A4
(en)
*
|
2002-06-07 |
2006-09-06 |
Univ Duke |
Substituted porphyrins
|
|
US6835387B2
(en)
|
2002-06-11 |
2004-12-28 |
Scimed Life Systems, Inc. |
Sustained release of superoxide dismutase mimics from implantable or insertable medical devices
|
|
US20040101521A1
(en)
*
|
2002-07-12 |
2004-05-27 |
The Buck Institute For Research On Aging |
Iron sequestration or elimination to reduce neurodegeneration or Parkinsons disease progression
|
|
WO2004012652A2
(en)
*
|
2002-08-02 |
2004-02-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Treatment of multiple sclerosis with brain targeted anti oxidant compounds
|
|
WO2004017959A2
(en)
*
|
2002-08-22 |
2004-03-04 |
University Of Florida |
Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
|
|
US20040044220A1
(en)
*
|
2002-08-22 |
2004-03-04 |
University Of Florida |
Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
|
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
|
US6964365B2
(en)
*
|
2003-05-07 |
2005-11-15 |
Mt Pleasant Gregory |
Library card holder
|
|
US7299082B2
(en)
|
2003-10-31 |
2007-11-20 |
Abbott Diabetes Care, Inc. |
Method of calibrating an analyte-measurement device, and associated methods, devices and systems
|
|
US7699964B2
(en)
|
2004-02-09 |
2010-04-20 |
Abbott Diabetes Care Inc. |
Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
|
|
US8165651B2
(en)
|
2004-02-09 |
2012-04-24 |
Abbott Diabetes Care Inc. |
Analyte sensor, and associated system and method employing a catalytic agent
|
|
ITTO20040124A1
(it)
*
|
2004-03-01 |
2004-06-01 |
Medestea Internaz Srl |
Nuovi impieghi in terapia di derivati di n-piperidina particolarmente per il trattamento di patologie neurodegenerative
|
|
FR2875500A1
(fr)
*
|
2004-09-21 |
2006-03-24 |
Centre Nat Rech Scient |
Complexe chiraux macrocycliques utilisables comme catalyseurs
|
|
US20060121016A1
(en)
*
|
2004-10-18 |
2006-06-08 |
Lee Raphael C |
Methods and compositions for treatment of free radical injury
|
|
US20060121101A1
(en)
*
|
2004-12-08 |
2006-06-08 |
Ladizinsky Daniel A |
Method for oxygen treatment of intact skin
|
|
US9044462B2
(en)
|
2004-12-08 |
2015-06-02 |
Avent, Inc. |
Method for oxygen treatment of intact skin
|
|
US8993627B2
(en)
|
2005-04-21 |
2015-03-31 |
Sentient Lifesciences, Inc. |
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
|
|
KR20080028357A
(ko)
*
|
2005-04-21 |
2008-03-31 |
글렌 에이. 골드스타인 |
산화성 스트레스에 관련된 질병 및 증상 치료용ｎ-아세틸시스테인 아미드(ｎａｃ 아미드)
|
|
EP1948066A2
(en)
*
|
2005-11-18 |
2008-07-30 |
Apexum Ltd. |
Ablating apparatus particularly useful for removal of dental periapical lesions
|
|
US7885698B2
(en)
|
2006-02-28 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Method and system for providing continuous calibration of implantable analyte sensors
|
|
GB0607096D0
(en)
*
|
2006-04-07 |
2006-05-17 |
Imp Innovations Ltd |
Compound
|
|
US8246975B2
(en)
|
2006-06-28 |
2012-08-21 |
Ihi Corporation |
Drug, drug guidance system, magnetic detection system, and drug design method
|
|
US7724491B2
(en)
*
|
2006-09-14 |
2010-05-25 |
Earth Fx, Inc. |
Method of treating inflammation and autoimmune diseases
|
|
US8735154B2
(en)
|
2006-10-30 |
2014-05-27 |
The University Of Kansas |
Templated islet cells and small islet cell clusters for diabetes treatment
|
|
US8252780B2
(en)
*
|
2006-12-01 |
2012-08-28 |
Women & Infants' Hospital |
Organometallic complexes as therapeutic agents
|
|
EP1949899A1
(en)
*
|
2007-01-23 |
2008-07-30 |
Freie Universität Berlin |
Metal salophen complexes use in prevention and treatment of cancer
|
|
JP4753922B2
(ja)
*
|
2007-09-27 |
2011-08-24 |
肇 小座野 |
化粧料用原料
|
|
US20090169484A1
(en)
*
|
2007-12-28 |
2009-07-02 |
Ihi Corporation |
Iron-salen complex
|
|
JP2009274962A
(ja)
*
|
2008-05-12 |
2009-11-26 |
Yoshihiro Ishikawa |
鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
|
|
EP2732817B1
(en)
|
2008-05-23 |
2016-08-24 |
National Jewish Health |
A compound for use in treating injury associated with exposure to phosgene or chlorine gas
|
|
US20100098768A1
(en)
*
|
2008-10-16 |
2010-04-22 |
Clarkson University |
Method of neuroprotection from oxidant injury using metal oxide nanoparticles
|
|
RU2495045C2
(ru)
*
|
2008-11-20 |
2013-10-10 |
АйЭйчАй КОРПОРЕЙШН |
Комплексное соединение самонамагничивающегося металла с саленом
|
|
KR101050273B1
(ko)
|
2008-11-21 |
2011-07-19 |
세종대학교산학협력단 |
살렌 전이금속 착화합물, 및 그 제조 방법
|
|
US9132090B2
(en)
*
|
2009-01-13 |
2015-09-15 |
Chetan Majmudar |
Propofol based anesthetic with preservative
|
|
EP2473037B1
(en)
*
|
2009-09-04 |
2016-03-09 |
Munisekhar Medasani |
Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
|
|
EP2564852B1
(en)
*
|
2010-04-28 |
2015-02-25 |
IHI Corporation |
Anti-brain-tumor drug
|
|
JP5873656B2
(ja)
*
|
2011-06-13 |
2016-03-01 |
株式会社Ihi |
金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤
|
|
JP6110379B2
(ja)
*
|
2011-07-18 |
2017-04-05 |
ノボマー， インコーポレイテッド |
金属錯体
|
|
WO2013016544A2
(en)
|
2011-07-27 |
2013-01-31 |
University Of Kansas |
Templated islet cells and small islet cell clusters for diabetes treatment
|
|
JP6046338B2
(ja)
*
|
2011-10-27 |
2016-12-14 |
株式会社Ihi |
ラジカル抑制剤
|
|
WO2013062779A1
(en)
|
2011-10-28 |
2013-05-02 |
E. I. Du Pont De Nemours And Company |
Treated inorganic core particles having improved dispersability
|
|
EP2771410B1
(en)
|
2011-10-28 |
2016-11-23 |
The Chemours Company TT, LLC |
Treated inorganic pigments having improved dispersability and use thereof in coating compositions
|
|
EP2771411B1
(en)
*
|
2011-10-28 |
2016-11-23 |
The Chemours Company TT, LLC |
Treated inorganic pigments having improved dispersability and use thereof in paper products
|
|
ES2761880T3
(es)
|
2012-08-24 |
2020-05-21 |
Saudi Aramco Tech Co |
Complejos metálicos
|
|
CZ304883B6
(cs)
*
|
2013-06-10 |
2014-12-29 |
Univerzita Palackého |
Salophenové komplexy železa s heterocyklickými N-donorovými ligandy, způsob jejich přípravy a jejich použití jako léčiv v protinádorové terapii
|
|
AU2014374361B9
(en)
|
2013-12-31 |
2019-07-04 |
Abbott Diabetes Care Inc. |
Self-powered analyte sensor and devices using the same
|
|
JP5806356B2
(ja)
*
|
2014-03-10 |
2015-11-10 |
株式会社Ihi |
鉄サレン錯体、磁性を有する薬剤、薬剤の誘導システム、並びに磁気検出装置
|
|
WO2016197089A1
(en)
*
|
2015-06-05 |
2016-12-08 |
Goldstein Glenn A |
Use of n-acetylcysteine amide in the treatment of acetaminophen overdose
|
|
US11154619B2
(en)
|
2017-02-17 |
2021-10-26 |
Creighton University |
Liposomal compositions with light illumination-induced drug release
|
|
CN113061259B
(zh)
*
|
2021-03-14 |
2022-03-29 |
华中科技大学同济医学院附属协和医院 |
用于缺血性脑卒中治疗的金属有机框架材料的制备方法
|